Free Trial

Ultragenyx Pharmaceutical (RARE) Income Statement & Balance Sheet

$44.86
-0.20 (-0.44%)
(As of 07/26/2024 ET)

Ultragenyx Pharmaceutical Income Statement, Balance Sheet and Cash Flow Statement


This page (NASDAQ:RARE) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners